1. Home
  2. MDXH vs PROV Comparison

MDXH vs PROV Comparison

Compare MDXH & PROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • PROV
  • Stock Information
  • Founded
  • MDXH 2003
  • PROV 1956
  • Country
  • MDXH Belgium
  • PROV United States
  • Employees
  • MDXH N/A
  • PROV N/A
  • Industry
  • MDXH
  • PROV Savings Institutions
  • Sector
  • MDXH
  • PROV Finance
  • Exchange
  • MDXH Nasdaq
  • PROV Nasdaq
  • Market Cap
  • MDXH 93.1M
  • PROV 107.5M
  • IPO Year
  • MDXH 2021
  • PROV 1996
  • Fundamental
  • Price
  • MDXH $1.86
  • PROV $15.59
  • Analyst Decision
  • MDXH Strong Buy
  • PROV Hold
  • Analyst Count
  • MDXH 2
  • PROV 1
  • Target Price
  • MDXH $7.00
  • PROV $16.00
  • AVG Volume (30 Days)
  • MDXH 58.0K
  • PROV 4.5K
  • Earning Date
  • MDXH 02-26-2025
  • PROV 01-28-2025
  • Dividend Yield
  • MDXH N/A
  • PROV 3.59%
  • EPS Growth
  • MDXH N/A
  • PROV N/A
  • EPS
  • MDXH N/A
  • PROV 0.91
  • Revenue
  • MDXH $84,708,000.00
  • PROV $38,443,000.00
  • Revenue This Year
  • MDXH $28.76
  • PROV N/A
  • Revenue Next Year
  • MDXH $19.91
  • PROV $9.89
  • P/E Ratio
  • MDXH N/A
  • PROV $17.15
  • Revenue Growth
  • MDXH 33.01
  • PROV N/A
  • 52 Week Low
  • MDXH $1.55
  • PROV $12.01
  • 52 Week High
  • MDXH $3.85
  • PROV $16.70
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 41.65
  • PROV 45.90
  • Support Level
  • MDXH $1.82
  • PROV $15.41
  • Resistance Level
  • MDXH $2.01
  • PROV $15.85
  • Average True Range (ATR)
  • MDXH 0.09
  • PROV 0.25
  • MACD
  • MDXH 0.01
  • PROV -0.04
  • Stochastic Oscillator
  • MDXH 46.43
  • PROV 18.95

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.

Share on Social Networks: